---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-064353"
form_type: "8-K"
ticker: "RGNX"
cik: "0001590877"
company_name: "REGENXBIO Inc."
filed_at: "2024-03-11T23:59:59+00:00"
generated_at: "2026-06-04T23:50:37.257492+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# REGENXBIO prices upsized public offering of common stock and pre-funded warrants at $23.00 per share

## Summary
- Offering includes 4,565,260 shares at $23.00 and 1,521,740 pre-funded warrants at $22.9999, with gross proceeds ~$140M.
- Net proceeds expected ~$131.2M (or $150.9M if underwriters fully exercise 30-day option for 913,050 additional shares).
- Underwriters include Morgan Stanley, Goldman Sachs, Barclays, and Stifel as joint book-running managers.
- Pre-funded warrants have $0.0001 exercise price, are exercisable immediately, and do not expire.
- Offering expected to close March 11, 2024, under shelf registration statement (File No. 333-269086).

## SEC filing metadata
- accession: 0001193125-24-064353
- form_type: 8-K
- ticker: RGNX
- cik: 0001590877
- company_name: REGENXBIO Inc.
- filed_at: 2024-03-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1590877/000119312524064353/0001193125-24-064353-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1590877/000119312524064353/d795828d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-064353
- JSON: https://secwatch.observer/filing/0001193125-24-064353.json
- Plain text: https://secwatch.observer/filing/0001193125-24-064353.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.